Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|May 13, 2019
Repeatability and reproducibility of relative cerebral blood volume measurement of recurrent glioma in a multicentre trial settingMarion Smits, Martin Bendszus, Sandra Collette, et al.Japanese Journal of Clinical Oncology|October 27, 2022
Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trialYoshihiko Tomita, Ko Kobayashi, Go Kimura, et al.Melanoma Research|May 7, 2011
Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-α (EORTC 18952) and prognostic value on treatment outcomeMarna G Bouwhuis, Sandra Collette, Stefan Suciu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986Maria De Santis, Joaquim Bellmunt, Graham Mead, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2018
Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysisAndré N Abrunhosa-Branquinho, Raquel Bar-Deroma, Sandra Collette, et al.European Journal of Cancer (Oxford, England : 1990)|October 2, 2009
Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study)Alberto Fusi, Sandra Collette, Antonia Busse, et al.European Journal of Cancer (Oxford, England : 1990)|March 24, 2018
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'Patrick Schöffski, Agnieszka Wozniak, Michael G Leahy, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2018
Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042)Damien C Weber, Carmen Ares, Salvador Villa, et al.International Journal of Clinical Oncology|June 21, 2019
Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analysesChikara Ohyama, Takahiro Kojima, Tsunenori Kondo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987Joaquim Bellmunt, Hans von der Maase, Graham M Mead, et al.Pageof 5